Why the study?
Giant cell myocarditis is a rare, devastating inflammatory cardiac disease with challenging early diagnosis, high mortality, and need for standardized treatment and research priorities.
Design
Review
Key result
Giant cell myocarditis is a rare, predominantly T cell-mediated autoimmune disorder requiring prompt diagnosis via endomyocardial biopsy and early initiation of combination immunosuppressive therapy.
Authors
Loading...
May inform T-cell targeted immunosuppression in GCM; leaves open need for prospective trials to guide therapy.
Giant cell myocarditis is a rare, devastating inflammatory cardiac disease requiring prompt diagnosis via endomyocardial biopsy and early initiation of combination immunosuppressive therapy to improve survival.
Vosko et al. (2026) conducted a review in Giant cell myocarditis. Immunosuppressive therapy and mechanical circulatory support was evaluated. Giant cell myocarditis is a rare, predominantly T cell-mediated autoimmune disorder requiring prompt diagnosis via endomyocardial biopsy and early initiation of combination immunosuppressive therapy.